Fountain of Youth | Clinician-Reviewed Peptide Therapy

What happens next

A calm, online process

Treatment availability depends on eligibility and clinician review. Nothing on this page guarantees prescribing, approval, or specific outcomes.

Complete your intake

A short intake captures the context your provider needs to review your file.

Clinician chart review

A licensed clinician reviews your information and approves, requests more, or declines treatment.

Discreet fulfillment

When prescribed, fulfillment is handled through the partnered pharmacy with discreet packaging.

Treatment is determined by a licensed clinician after review. Not all patients are candidates. Individual results vary.

About Fountain of Youth

What it is, how it works, what it's studied for, and safety considerations.

Fountain of Youth is a compounded multi-peptide blend combining GHK-Cu, BPC-157, TB-500, and Epitalon, offered for clinician-supervised recovery and longevity discussion. This page is educational and not medical advice.

Last updated: July 2, 2026

What Is Fountain of Youth?

This blend combines four peptides: GHK-Cu (a copper-binding tripeptide studied in skin and tissue-remodeling research), BPC-157 (a synthetic peptide studied in preclinical repair models), TB-500 (a fragment related to thymosin beta-4), and Epitalon (a synthetic tetrapeptide discussed in longevity research). The blend is not FDA-approved, and its components differ widely in evidence and regulatory status.

How It Works

GHK-Cu is studied for signaling related to collagen, elastin, and tissue remodeling; BPC-157 and TB-500 are studied in preclinical tissue-repair models; Epitalon is discussed in preliminary research around pineal/telomere-related pathways. The combined mechanism in humans is not an established clinical effect.

What It’s Studied For

GHK-Cu has research in skin remodeling and wound healing (much of the strongest use is topical/cosmetic); BPC-157 and TB-500 are preclinical-dominant; Epitalon has very limited, largely preclinical or early human research, and its longevity/anti-aging claims are not established. None of these injectable uses is FDA-approved, and the blend has no controlled human outcome trials.

Regulatory Status

The FDA has flagged BPC-157 in its 503A bulk-substance review (Category 2, safety concerns); BPC-157 and TB-500-related substances have been part of FDA compounding-safety discussions and are WADA-prohibited for athletes; injectable GHK-Cu and Epitalon have limited human safety data. Compounding availability is subject to each component's status.

What to Expect

Use is provider-directed only; no anti-aging, longevity, or recovery outcome or timeline is promised, and effects are individual and unverified for these purposes.

Preferred Starting Options / Dosing Notes

Many patients begin with a lower starting option so a licensed clinician can evaluate tolerance, medical history, goals, and safety factors before any adjustments are considered. The starting option shown below is informational and reflects available program data, not self-directed dosing instructions. Final medication, dose, frequency, and treatment plan are determined by a licensed clinician.

Average starting option

5 mL

Available options

5 mL

Provider note: Do not change dose, frequency, or route of use unless directed by your clinician.

Safety Considerations

Risks may be additive across a four-peptide blend and include injection-site reactions, hypersensitivity, copper-related considerations (GHK-Cu), immunogenicity, and purity/sterility concerns, with limited human data for several components and unknown long-term safety of stacked peptide use.
No peptide is "safe" without qualification.

Important note

Some treatments may involve compounded medications when prescribed by a clinician. Compounded medications are not FDA-approved. The FDA does not evaluate compounded medications for safety, effectiveness, or quality before marketing.

Who Is Not a Candidate

A clinician reviews skin/collagen and recovery goals, copper-related and liver considerations, cancer history, immune status, pregnancy status, allergies, and medications before considering the blend, and may determine it is not appropriate.

How It Compares

Compared with any single component, the blend layers four peptides of differing and largely preliminary evidence, increasing uncertainty and additive-risk considerations. None is presented as superior.

Frequently Asked Questions

Is Fountain of Youth FDA-approved?

No — the blend is not FDA-approved, and its injectable components are not FDA-approved for these uses.

What is in it?

GHK-Cu, BPC-157, TB-500, and Epitalon.

What are the risks?

Additive risks including injection-site/hypersensitivity reactions, copper considerations, immunogenicity, and purity concerns, with limited human data.

Does payment guarantee a prescription?

No — a licensed clinician decides.

References

Peer-reviewed literature on GHK-Cu, BPC-157, thymosin beta-4/TB-500, and Epitalon (PubMed)
FDA compounding-safety communications
WADA Prohibited List

Disclaimer

Although the information on this page is based on available educational research and product information, it is provided for informational purposes only and is not medical advice. Treatment decisions, medication selection, dosing, and eligibility are determined by a licensed clinician after review. Not all patients are candidates, and individual results may vary. Use medications only as directed by your clinician.

Learn more about Fountain of Youth

Important safety information

This page is informational and does not replace medical advice from a licensed professional. Treatment availability depends on eligibility, clinician review, and applicable requirements. ElliotMeds does not provide emergency medical services — if you are experiencing a medical emergency, call 911 or go to the nearest emergency room.